P-26 EPIDEMIOLOGICAL DATA AND SURVIVAL OF LUNG CANCER IN INDONESIA
1DHARMAIS CANCER HOSPITAL, Indonesia, 2Departmen of Pulmonology, “Dharmais” National Cancer Hospital, 3Department of Thoracic Surgery, "Dharmais" National Cancer Hospital, 4Department of Pathologic, "Dharmais" National Cancer Hospital, 5Department of Radiology, "Dharmais" National Cancer Hospital
P-27 A retrospective analysis of the efficacy of more than third line chemotherapy
Department of Hematology and Oncology, Holy Family Hospital, Catholic University of Korea, Korea
P-28 Human T-cell Iymphotropic Virus Type I (HTLV-I) Transmission in north west of Iran
Department of Internal medicine, Urmia University of Medical Sciences, Iran
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Germany, 2Manila Cancer Registry, Philippine Cancer Society,Philippines, 3Department of Health-Rizal Cancer Registry, Rizal Medical Center, Philippines, 4Department of Surgery, Philippine General Hospital, University of the Philippines, Philippines, 5Department of Obstetric and Gynecology, Philippine General Hospital, University of the Philippines Manila, Philippines
P-30 WITHDRAWN
P-31 Trends of Cervix Uteri Cancer Incidence Rates in Kazakhstan
Kazakh Research Institute of Oncology and Radiology, Kazakhstan
1Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Japan, 2Department of Public Health, Aichi Medical University School of Medicine, 3Seirei Social Welfare Community
P-33 WITHDRAWN
1Department of Epidemiology & Biostatstics, College of Public Health University of the Philippines-Manila, Philippines, 2Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Germany, 3Department of Surgery, Philippine General Hospital, University of the Philippines Manila; Philippine Cancer Society-Manila Cancer Registry; Department of Health-Rizal Cancer Registry, Philippines, 4Philippine Cancer Society-Manila Cancer Registry; Department of Health-Rizal Cancer Registry, Philippines
P-35 Daiko Study of the Japan Multi-Institutional Collaborative Cohort Study: a progress report
1Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Japan, 2Department of Nursing, Nagoya University, Japan, 3Department of Nursing, Nagoya University, 4Pathophysiological Laboratory Sciences, Nagoya University, Japan, 5Department of Geriatrics, Nagoya University Graduate School of Medicine, Japan
P-36 WITHDRAWN